The Men's

The Men's is a Brazilian digital health platform founded in March 2021 by CEO Danilo Bertasi. The company operates as a direct-to-patient health hub, providing online medical consultations and personalized treatments to destigmatize men's health care. Bertasi, who previously worked in finance at Ambev, launched the startup to address a market he felt was underserved and often treated as an extension of women's products.

The company's business model combines an e-commerce platform with telemedicine services, allowing users to access medical consultations and receive treatments directly from their mobile devices. The platform uses data collected from users to identify behavioral patterns and specific medical needs, enabling the creation of customized products. The Men's offers a range of exclusive products for hair loss, skin and beard care, sexual health, sleep, and overall well-being. Its initial product was a hair loss treatment kit, and it has since expanded to include items like "Chocosono," a melatonin-based chocolate product for sleep that has gained popularity among a wider audience.

The Men's has secured significant funding to fuel its growth. In late 2021, the company raised $1 million in a seed round from Eurofarma's Neuron Ventures and MIT Alumni Angels. More recently, in January 2025, it secured approximately $424,000 (R$ 2.6 million) in a round led by BR Angels, with continued support from Eurofarma. These funds are intended to support the launch of new products in areas like weight loss and to enhance brand recognition. The company's strategy is to follow the path of successful U.S. healthtechs like Hims & Hers and Roman.

Keywords: men's health, digital health, telemedicine, e-commerce, personalized medicine, hair loss treatment, sexual wellness, skincare, direct-to-patient, healthtech, Brazil, Danilo Bertasi, online consultation, men's wellness